ApexBio established in the Hsinchu Science-based Industrial Park since December 1997, the main products are used biosensor technology to create home care medical device for chronic disease patients to maintain and control their health. ApexBio successfully became the first IPO listed biotechnology company in 2000.

ApexBio was founded to develop into a full range of IVD company and is actively engaged in the research, development, manufacture and sales worldwide. At beginning using biosensor technology to develop a self-testing handheld blood glucose monitoring systems, uric acid, hemoglobin, cholesterol, lactate, HbA1C, ketone, coagulation and multifunctional self-testing systems. Our Products have been approved by CE, FDA, TFDA, CFDA, ANVISA and our manufacturing facilities also have been notified by Taiwan GMP, Brazil GMP, ISO 9001 & 13485, and FDA.